Red Light Holland (TRIP.C) and Australian-based cannabis company, Creso Pharma Limited (CPH.ASX) cancelled their previously announced merger today, according to a press release. The merger was originally announced…
CPH.ASX
Cedar Clinical Research Novamind (NM.C) announced today it’s increasing its investment in the Australian-based drug company Bionomics (BNO.ASX). The company is focused primarily on anxiety, PTSD, and central nervous…
The CPH circus looks to be leaving town after Canadian listed PharmaCielo (PCLO.V) made an all-scrip AUD $122M offer to acquire Creso Pharma (CPH.ASX), which equated to AUD 0.63…
A late Fumble today folks – been one of those weeks where no matter how much I flooded my body with Berocca it just wouldn’t respond 🙁 Good to…
Muay Thai is the national sport here in my adopted homeland. Known as ‘the science of eight limbs‘ it’s a brutal contest – a knee or elbow to the…
On the surface, the rights issue announced by Creso Pharma (CPH.ASX) looks to be a decent deal for long-suffering shareholders, albeit it a little unusual. The rights issue is…
Confirmation bias is our tendency to cherry-pick information that confirms our existing beliefs or ideas. Think about the following statements: • Obama was not born in America. • Iraq…
Anyone who has followed the Creso Pharma (CPH.ASX) story over the past year was aghast when they read the recent company announcement revealing that CPH issued Assena Wealth Solutions…
Did we tell you, or did we tell you? No surprise as here at Equity Guru we have quite the track record at nailing market calls. As 2017 was…
While the first snow recently dusted the streets of Vancouver, Sydneysiders have sweltered with temperatures soaring past 43 degrees Celcius (109°F) this past weekend. The financial glitterati are making…